Remodeling of the liver fibrosis microenvironment based on nilotinib-loaded multicatalytic nanozymes with boosted antifibrogenic activity

Liver fibrosis is a reversible pathological process caused by chronic liver damage and a major risk factor for hepatocellular carcinoma (HCC). Hepatic stellate cell (HSC) activation is considered the main target for liver fibrosis therapy. However, the efficiency of this strategy is limited due to t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Huaqing Jing (Autor), Yingzi Ren (Autor), Yue Zhou (Autor), Min Xu (Autor), Sona Krizkova (Autor), Zbynek Heger (Autor), Qiang Lu (Autor), Siyu Wang (Autor), Xiaoyang Liang (Autor), Vojtech Adam (Autor), Nan Li (Autor)
Formato: Libro
Publicado: Elsevier, 2023-12-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible